GlassScriptPhysician profile
Ana Arroyo
NPI 1295701050
$1,735.88
in general payments reported to CMS, 2019-2025
10 companies · $234 in 2025
The $234 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $374 · 2020: $20.00 · 2021: $342 · 2022: $212 · 2023: $308 · 2024: $247 · 2025: $234.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $763 · Education: $25.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $763.27 |
| Education | $25.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biocryst US Sales Co., LLC | $644.32 | 2022-2025 | Orladeyo |
| Merck Sharp & Dohme LLC | $335.99 | 2019-2025 | Vaxneuvance, Gardasil 9, Enflonsia |
| Teva Pharmaceuticals USA, INC. | $236.89 | 2021 | |
| Pfizer INC. | $127.50 | 2021-2023 | |
| Astrazeneca Pharmaceuticals LP | $100.00 | 2019 | |
| Pfizer Pharmaceuticals LLC | $100.00 | 2019 | |
| Glaxosmithkline, LLC. | $100.00 | 2019 | |
| Pbg Puerto Rico LLC | $38.51 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.27 | 2021 | |
| Abbvie INC. | $21.40 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ana Arroyo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.